Jonathan Allen

In this engaging discussion, Jim Brase, Felice Lightstone, and Jonathan Allen from Lawrence Livermore National Laboratory share insights on reshaping drug discovery with advanced computing. They explore how high-performance computing and AI are revolutionizing the identification and testing of new treatments, targeting diseases more precisely than ever. Topics include the innovative use of physics-based simulations, the challenges in drug development, and promising advancements like effective drugs for the 'undruggable' RAS protein. Their optimism shines as they announce new molecular designs entering trials.